STM publisher Elsevier, Netherlands, has announced that its journal Vaccine has released a supplement dedicated to vaccines for biodefence during the ‘Vaccines for Biothreats and Emerging and Neglected Diseases Symposium’ in Galveston, Texas, USA. It seeks to provide a comprehensive overview on vaccines that have been developed against a diverse group of human and veterinary pathogens, including Bacillus anthracis, smallpox and blue tongue.
The supplement was launched at the third in a series of symposia around the theme of ‘The Changing Landscape of Vaccine Development’. The symposia were organised by the Sealy Center for Vaccine Development at the University of Texas Medical Branch in conjunction with the James W. McLaughlin Fellowship Fund. The supplement is edited by Alan Barrett of the University of Texas Medial Branch; Shan Lu of the University of Massachusetts; and Greg Poland of the Mayo Clinic Vaccine Research Group.
Biodefense has traditionally been associated with defence against biological warfare agents with an emphasis on military applications. As research continues to develop biodefence countermeasures, vaccines are seen as a critical component of the portfolio to control biothreats.
Vaccine is positioned as an interface between academics, those in research and development, and workers in the field. Relevant topics range from basic research through to applications, safety and legislation.
Search for more such STM publishing books/journals in K-Store
Discuss this NEWS
